SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-265268
Filing Date
2023-10-27
Accepted
2023-10-27 17:17:56
Documents
14
Period of Report
2023-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d576763d8k.htm   iXBRL 8-K 48986
2 EX-10.1 d576763dex101.htm EX-10.1 94746
3 EX-10.2 d576763dex102.htm EX-10.2 16664
  Complete submission text file 0001193125-23-265268.txt   322073

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA trml-20231023.xsd EX-101.SCH 2845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE trml-20231023_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trml-20231023_pre.xml EX-101.PRE 11704
8 EXTRACTED XBRL INSTANCE DOCUMENT d576763d8k_htm.xml XML 3467
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 231356403
SIC: 2836 Biological Products, (No Diagnostic Substances)